Predictive and Presymptomatic Testing Market Share

Statistics for the 2023 & 2024 Predictive and Presymptomatic Testing market share, created by Mordor Intelligence™ Industry Reports. Predictive and Presymptomatic Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Predictive and Presymptomatic Testing Industry Market Share

Market Share of Predictive and Presymptomatic Testing Industry

The predictive and presymptomatic testing market is moderately competitive and is majorly comprised of local players in different countries. Some of the global players such as 23andMe, Abbott Laboratories, and Myriad Genetics hold a major share of the market. With the growing focus on genetic testing, it is expected that a few small to mid-sized companies will penetrate the market in the near future.

Predictive and Presymptomatic Testing Market Leaders

  1. 23andMe

  2. Abbott Laboratories

  3. Quest Diagnostics Inc.

  4. Myriad Genetics

  5. Positive Bioscience

*Disclaimer: Major Players sorted in no particular order

Predictive and Presymptomatic Testing Market Concentration

Predictive and Presymptomatic Testing Market Report Snapshots

Predictive Presymptomatic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)